SMMT CIK: 1599298

Summit Therapeutics Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
billions USD
FY21:
−0.07
FY22:
−0.04
FY23:
−0.08
FY24:
−0.14
FY25:
−0.32
Change from FY21 to FY25
billions USD
FY21:
0.00
FY22:
0.00
FY23:
−0.59
FY24:
−0.21
FY25:
−0.17
Change from FY21 to FY25
billions USD
FY21:
0.08
FY22:
0.62
FY23:
0.09
FY24:
0.38
FY25:
0.62
billions USD
FY21:
0.01
FY22:
0.58
FY23:
−0.58
FY24:
0.03
FY25:
0.12
(positive)
Change from FY21 to FY25
billions USD
FY21:
−0.07
FY22:
−0.04
FY23:
−0.08
FY24:
−0.14
FY25:
−0.32

All amounts in billions USD Data source:SEC EDGAR